Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Intravenous Bonalon approved in Japan

Jan. 23, 2012

Novel glucagon analogues described

Jan. 23, 2012

Novartis announces CHMP opinion on Signifor

Jan. 23, 2012

Novel chemokine CCR2 receptor antagonists disclosed by Janssen

Jan. 20, 2012

Trimel Pharmaceuticals advances phase III CompleoTRT study

Jan. 20, 2012

FDA issues complete response letter regarding dapagliflozin

Jan. 19, 2012

PROLOR Biotech presents topline data on hGH-CTP

Jan. 19, 2012

Novel compounds acting on urate transporter patented by Ardea Bisociences

Jan. 19, 2012

Ardea Biosciences discloses new inhibitors of urate transport

Jan. 18, 2012

LoneStar Heart acquires exclusive worldwide license

Jan. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.